Showing results (1881-1890 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|May 25, 2011
Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune responseAkitaka Takahara, Shigeo Koido, Masaki Ito, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Paradoxical enhancement of interleukin-2-mediated cytotoxicity against K562 cells by addition of a low dose of methotrexateT Nakarai, Y Ueno, Y Ueno, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2011
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinomaHirohito Kobayashi, Yoshimasa Tanaka, Junji Yagi, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2011
Enhanced anti-tumor immunity by superantigen-pulsed dendritic cellsMasato Kato, Yutaro Nakamura, Takafumi Suda, et al.
Cancer Immunology, Immunotherapy : CII|June 30, 2011
In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cellsArchana Thakur, Oxana Norkina, Lawrence G Lum
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancersGoki Shindo, Takayoshi Endo, Masamitsu Onda, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicitySebastian F M Häusler, Itsaso Montalbán del Barrio, Jenny Strohschein, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse modelDavid M Foureau, Iain H McKillop, Chase P Jones, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancerS Rasoul-Rockenschaub, C C Zielinski, C Müller, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2011
Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietinHui Li, Hua Zhao, Jinpu Yu, et al.
Pageof 652